
Rtsunate SP 50mg/500mg/25mg Tablet
Marketer
Themis Medicare Ltd
Salt Composition
Artesunate (50mg) + Sulphadoxine (500mg) + Pyrimethamine (25mg)
Overview Rtsunate SP 50mg/500mg/25mg Tablet
Malarone SP 50mg/500mg/25mg tablets combat malaria by inhibiting parasitic growth. This prescription medication, containing a combination of active ingredients, should be taken regularly with food at the same time each day. Always adhere to your doctor's prescribed dosage and duration; exceeding the recommended amount can be harmful. If a dose is missed, take it immediately upon remembering. Complete the entire course for optimal results. Potential side effects include fatigue, nausea, headache, and mouth sores. Persistent side effects warrant medical attention. Prior to use, inform your doctor of any antibiotic allergies (particularly sulfa drugs), kidney or liver issues. Pregnant or breastfeeding individuals must consult their doctor before use. Regular blood and urine tests may be conducted during treatment to monitor your health.
Primary Ingredients of Rtsunate SP 50mg/500mg/25mg Tablet
No text provided to rephrase.
Uses of Rtsunate SP 50mg/500mg/25mg Tablet
Managing Malaria Infections
Major Benefits of Rtsunate SP 50mg/500mg/25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Rtsunate SP 50mg/500mg/25mg Tablets should be administered with a meal.
Common Side effects of Rtsunate SP 50mg/500mg/25mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Feeling of fullness
- Mouth sore
- Skin rash
- Fatigue
- Headache
- Dizziness
- Upset stomach
- ECG changes
How to use Rtsunate SP 50mg/500mg/25mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Rtsunate SP 50mg/500mg/25mg tablets should be administered with a meal.
How Rtsunate SP 50mg/500mg/25mg Tablet works:
Combiflam-Mal 50mg/500mg/25mg tablets combine artesunate, sulphadoxine, and pyrimethamine to combat malaria. Artesunate and pyrimethamine, antiparasitic agents, elevate blood heme levels, a substance harmful to the malaria parasite, thereby eliminating the parasite and halting infection progression. Sulphadoxine, an antibacterial agent, inhibits bacterial folic acid synthesis, a crucial nutrient for bacterial reproduction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rtsunate SP 50mg/500mg/25mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rtsunate SP 50mg/500mg/25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Rtsunate SP 50mg/500mg/25mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rtsunate SP 50mg/500mg/25mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Rtsunate SP 50mg/500mg/25mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Rtsunate SP 50mg/500mg/25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Rtsunate SP 50mg/500mg/25mg Tablet :
Should you forget a dose of Rtsunate SP 50mg/500mg/25mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rtsunate SP 50mg/500mg/25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Drugs |
